IBRN ETF

$34.64

Returns Overview

1 Month
-1.12%
3 Months
+6.98%
6 Months
+14.27%
YTD
+8.98%
1 Year
+29.04%
3 Years
+8.83%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IBRN have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-1.12%

3 Months Performance

+6.98%

6 Months Performance

+14.27%

1 Year Performance

+29.04%

Benchmark & Peers

Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index(NYFSNBMT)
This ETF (YTD)
+8.98%
Peer Avg (YTD)
+1.55%
vs Peers
+7.44%

IBRN ETF Performance

IBRN performance across multiple time periods: 1-month -1.12%, YTD 8.98%, 1-year 29.04%, 3-year 8.83%.

IBRN returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IBRN performance comparison shows side-by-side returns with another fund. IBRN alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-1.12%Apr 22, 2026 to May 22, 2026
3 Months+6.98%Feb 23, 2026 to May 22, 2026
6 Months+14.27%Nov 24, 2025 to May 22, 2026
1 Year+29.04%N/A
3 Years+8.83%N/A

All returns shown are total returns, not annualized